"The most prevalent subtype of endometriosis currently evades reliable detection, leaving women no choice for diagnosis other than invasive surgery."
"If these results are confirmed in larger phase 3 studies, imaging with maraciclatide could transform clinical research and practice and potentially empower the development of treatments for women across the globe."
"Research by the charity Endometriosis UK suggests women in England currently wait an average of 9 years 4 months, rising to 11 years for women from ethnic minority communities."
A trial involving 19 women indicates that maraciclatide, an experimental radiotracer, can effectively highlight endometriosis in scans. Currently, surgical investigation is necessary for diagnosis, causing significant delays, with women in England waiting nearly a decade. The most common subtype of endometriosis remains undetectable by existing imaging methods. If larger studies confirm these findings, maraciclatide imaging could revolutionize diagnosis and treatment options for women globally. Endometriosis affects about one in 10 women, causing various painful symptoms and impacting fertility.
Read at www.theguardian.com
Unable to calculate read time
Collection
[
|
...
]